Dr. Camilo Toro, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 187 Thomas Johnson Dr, Suite #3, Frederick, MD 21702 Phone: 301-631-0444 Fax: 301-631-0250 |
Andrew B. Johnson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5301 Buckeystown Pike, Frederick, MD 21704 Phone: 301-733-0330 Fax: 301-733-4038 |
Zakiya J Wynn, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 174 Thomas Johnson Dr, Ste 100, Frederick, MD 21702 Phone: 301-668-9380 Fax: 301-668-9430 |
Grace Thammasuvimol, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 170 Thomas Johnson Dr Ste 200, Frederick, MD 21702 Phone: 301-695-8390 Fax: 301-694-7906 |
News Archive
Today sees the presentation of a study that, for the first time, shows the results of treatment using prostheses attached to titanium implants in the bones of patients with above-the-knee amputations. It reveals that the treatment improves function and quality of life in nine out of ten patients, and is the result of research carried out at the Sahlgrenska Academy and Sahlgrenska University Hospital that is being presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Favipiravir Observational Study Group (principal investigator: Dr. Yohei Doi, Fujita Health University) released a preliminary report of the Favipiravir Observational Study in Japan on the Japanese Association for Infectious Diseases website.
A new study published in the American Journal of Respiratory and Critical Care Medicine shows that recording the way the organisms living within the lungs change in type and numbers could reflect the response of the critically ill patient to medical care. Though changes in the lung microbiome have been known to exist even before this study, this research shows the clinical importance of this test.
Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.
A single gene of the mother plays such a crucial role in the development of the placenta that its dysfunction leads to miscarriages.
› Verified 5 days ago